Please login to the form below

Not currently logged in
Email:
Password:

EMA reviews anti-inflammatory safety

The European Medicines Agency is to review the safety of non-selective non-steroidal anti-inflammatory drugs following new evidence into their association with cardiovascular events

The European Medicines Agency (EMA) is to review the safety of non-selective non-steroidal anti-inflammatory drugs following new evidence into their association with cardiovascular events.

The last review by the EMA took place in 2006, when the regulatory agency concluded the overall benefit-risk balance of the treatment remained positive, despite a small increased risk of events such as heart attacks or stroke.

Since then, several additional studies into the cardiovascular safety of NSAIDs have been published, including the independent meta-analysis project 'safety of non-steroidal anti-inflammatory drugs' (SOS) funded by the European Commission under the Seventh Framework Programme to evaluate the safety of NSAIDs.

The agency's Committee for Medicinal Products for Human Use (CHMP) will now review the results of this study, together with any other available clinical data post-marketing safety reports on non-selective NSAIDs, to clarify whether there is any need to update the opinion issued in 2006.

Non-selective NSAIDS are used in the relief of pain and inflammation in a wide range of conditions, including arthritic, acute musculo-skeletal disorders and other painful conditions resulting from trauma.

Treatments being reviewed include diclofenac, etodolac, ibuprofen, indomethacin, ketoprofen, meloxicam, nabumetone, naproxen, nimesulide and piroxicam.

24th October 2011

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Accession

Accession was a born from a passion and a vision. A passion to harness the power of market access to...

Latest intelligence

EU
Innovation in merger control and the impact on the pharmaceutical sector
Is focusing on pipeline products enough to assess regulatory risks?...
Nudge-nudge, think-think
Chris Ross examines the personal complexities of human behaviour – and explains why fun, emotion and peer endorsement could be key to designing effective behavioural change programmes...
Peoples Award
Quality in Care Diabetes 2018: the best in innovative diabetes care
Awards highlight new evidence-based approaches to improving care...

Infographics